Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Fujitsu Adopts ARM PHY & Standard Cells For 65 nm Platform
Thanks! If this coincidence has any substance behind it, it is an obvious bolstering of the MMP IP. The best legal minds behind Fujitsu MAY BE very nervous. Unbridled speculation on my part.
Share
New Message
Please login to post a reply